Search
ENDRA Life Sciences Inc
NDRAAdd to Watchlist
6.500USD
+0.270+4.33%
Close 09-22 16:00（ET）
13.85MMarket Cap
LossP/E TTM
ENDRA Life Sciences Inc (NDRA) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to ENDRA Life Sciences Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
25.000USD+301.28%
NDRA Analyst Recommendation Trends
In the current month, NDRA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NDRA average Analyst price target in the last month is 25.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
NDRA Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, NDRA EPS is projected to reach -0.840 in FY2026Q3, following reported EPS of 0.121 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.23
-1.23
-0.84
-0.84
-0.84
Actual
-2.85
-1.09
0.12
--
--
Surprise
-132.03%
+11.12%
+114.38%
--
--
FAQs
What is ENDRA Life Sciences Inc's price target?
Analysts forecast that ENDRA Life Sciences Inc's price target is USD 25.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 25.00.
How have ENDRA Life Sciences IncNDRA's recent earnings per share performed?
The market expectation was USD 0.12, while ENDRA Life Sciences IncNDRA's earnings per share (EPS) for the previous quarter was USD -1.09. EPS for the next quarter is expected at USD -0.84.
What is the analyst rating for ENDRA Life Sciences Inc?
Based on the ratings of ENDRA Life Sciences Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.